Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Stephen Waldo to Percutaneous Coronary Intervention

This is a "connection" page, showing publications Stephen Waldo has written about Percutaneous Coronary Intervention.

 
Connection Strength
  
 
 
19.373
  
  1. Kovach CP, Lipinski J, Mesenbring EC, Boulos P, Pribish A, Sola M, Glorioso TJ, Fearon WF, Yeh RW, Waldo SW. Characteristics and Outcomes of PCI Among Patients Ineligible for Surgical Revascularization in the Veterans Affairs Healthcare System. Circ Cardiovasc Interv. 2025 Mar; 18(3):e014899.
    View in: PubMed
    Score: 0.646
  2. Butala NM, Hebbe A, Shah B, Smilowitz NR, Aijaz B, Uzendu A, Boulos P, Waldo SW. Outcomes After Noncardiac Surgery Performed Within 2?Years of Percutaneous Coronary Intervention. J Am Heart Assoc. 2025 Mar 18; 14(6):e038807.
    View in: PubMed
    Score: 0.645
  3. Aijaz B, Glorioso TJ, Butala N, Waldo SW. Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program. Catheter Cardiovasc Interv. 2023 09; 102(3):503-504.
    View in: PubMed
    Score: 0.575
  4. Kovach CP, Hebbe A, Glorioso TJ, Barrett C, Bar?n AE, Mavromatis K, Valle JA, Waldo SW. Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022 12 26; 15(24):2475-2486.
    View in: PubMed
    Score: 0.553
  5. Kovach C, Banerjee S, Waldo S. Radial Artery Access for Acute Coronary Syndromes: a Review of Current Evidence. Curr Cardiol Rep. 2022 04; 24(4):383-392.
    View in: PubMed
    Score: 0.524
  6. Waldo SW, Glorioso TJ, Bar?n AE, Doll JA, Plomondon ME, Ho PM. Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program. J Am Heart Assoc. 2022 02 15; 11(4):e024598.
    View in: PubMed
    Score: 0.521
  7. Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Contemporary Clinical and Coronary Anatomic Risk Model for 30-Day Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2021 12; 14(12):e010863.
    View in: PubMed
    Score: 0.515
  8. Kovach CP, Hebbe A, Bar?n AE, Strobel A, Plomondon ME, Valle JA, Waldo SW. Clinical Characteristics and Outcomes Among Patients Undergoing High-Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2021 12 07; 10(23):e022131.
    View in: PubMed
    Score: 0.512
  9. Kovach CP, O'Donnell CI, Swat S, Doll JA, Plomondon ME, Schofield R, Valle JA, Waldo SW. Impact of Operator Volumes and Experience on Outcomes After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Cardiovasc Revasc Med. 2022 07; 40:64-68.
    View in: PubMed
    Score: 0.511
  10. Waldo SW, Hebbe A, Grunwald GK, Doll JA, Schofield R. Clinical and Anatomic Complexity of Patients Undergoing Coronary Intervention With and Without On-Site Surgical Capabilities: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Circ Cardiovasc Interv. 2021 01; 14(1):e009697.
    View in: PubMed
    Score: 0.481
  11. Waldo SW, Glorioso TJ, Bar?n AE, Plomondon ME, Valle JA, Schofield R, Ho PM. Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention at Veterans Affairs and Community Care Hospitals. J Am Coll Cardiol. 2020 09 01; 76(9):1112-1116.
    View in: PubMed
    Score: 0.471
  12. Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Development and Implementation of an In-Hospital Bleeding Risk Model for Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2021 07; 28:20-24.
    View in: PubMed
    Score: 0.468
  13. Barrett C, Warsavage T, Kovach C, McGuinn E, Plomondon ME, Armstrong EJ, Waldo SW. Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program. Catheter Cardiovasc Interv. 2021 02 01; 97(2):E219-E226.
    View in: PubMed
    Score: 0.462
  14. Prouse A, Gunzburger E, Yang F, Morrison J, Valle JA, Armstrong EJ, Waldo SW. Contemporary Use and Outcomes of Arterial Closure Devices After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2020 02 18; 9(4):e015223.
    View in: PubMed
    Score: 0.454
  15. Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
    View in: PubMed
    Score: 0.448
  16. Morrison J, Plomondon ME, O'Donnell CI, Giri J, Doll JA, Valle JA, Waldo SW. Perceptions of Public and Nonpublic Reporting of Interventional Cardiology Outcomes and Its Impact on Practice: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2019 11 19; 8(22):e014212.
    View in: PubMed
    Score: 0.446
  17. Waldo SW, Bricker RS. Moving Toward Accurate Calculation of Risk Without the Use of Calculators. Cardiovasc Revasc Med. 2019 11; 20(11):937-938.
    View in: PubMed
    Score: 0.445
  18. Doll JA, Plomondon ME, Waldo SW. Characteristics of the Quality Improvement Content of Cardiac Catheterization Peer Reviews in the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JAMA Netw Open. 2019 08 02; 2(8):e198393.
    View in: PubMed
    Score: 0.437
  19. Valle JA, Glorioso TJ, Bricker R, Bar?n AE, Armstrong EJ, Bhatt DL, Rao SV, Plomondon ME, Serruys PW, Keppetein AP, Sabik JF, Dressler O, Stone GW, Waldo SW. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program. JAMA Cardiol. 2019 08 01; 4(8):727-735.
    View in: PubMed
    Score: 0.437
  20. Valle JA, Glorioso TJ, Schuetze KB, Grunwald GK, Armstrong EJ, Waldo SW. Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention. Circ Cardiovasc Interv. 2019 05; 12(5):e007636.
    View in: PubMed
    Score: 0.429
  21. Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
    View in: PubMed
    Score: 0.429
  22. Bagai J, Hess E, Penny WF, Plomondon ME, Waldo SW. Outcomes of Transradial PCI compared to Transfemoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program. Cardiovasc Revasc Med. 2019 Nov; 20(11):990-996.
    View in: PubMed
    Score: 0.421
  23. Jawaid O, Stanislawski M, Bricker R, Plomondon ME, Grunwald GK, Valle JA, Armstrong EJ, Waldo SW. Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program. Coron Artery Dis. 2019 01; 30(1):44-50.
    View in: PubMed
    Score: 0.420
  24. Waldo SW, Gokhale M, O'Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary?Angiography and Percutaneous?Coronary?Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2018 05 14; 11(9):879-888.
    View in: PubMed
    Score: 0.402
  25. Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW. Variation in the Adoption of Transradial?Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry. JACC Cardiovasc Interv. 2017 11 27; 10(22):2242-2254.
    View in: PubMed
    Score: 0.387
  26. Armstrong EJ, Stanislawski MA, Kokkinidis DG, Plomondon ME, Bar?n AE, Giri J, Shunk KA, Banerjee S, Maddox TM, Waldo SW. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program. Catheter Cardiovasc Interv. 2018 05 01; 91(6):1009-1017.
    View in: PubMed
    Score: 0.381
  27. Waldo SW, O'Donnell CI, Prouse A, Plomondon ME, Rao SV, Maddox TM, Ho PM, Armstrong EJ. Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program. Catheter Cardiovasc Interv. 2018 02 15; 91(3):425-433.
    View in: PubMed
    Score: 0.378
  28. Waldo SW, McCabe JM, Kennedy KF, Zigler CM, Pinto DS, Yeh RW. Quality of Care at Hospitals Identified as Outliers in Publicly Reported Mortality Statistics for Percutaneous Coronary Intervention. Circulation. 2017 May 16; 135(20):1897-1907.
    View in: PubMed
    Score: 0.370
  29. Waldo SW, Abtahian F, Kennedy KF, Scirica BM, Mahmood S, Yeh RW. Incidence and predictors of incomplete revascularization in a contemporary cohort. Coron Artery Dis. 2016 May; 27(3):191-8.
    View in: PubMed
    Score: 0.349
  30. Waldo SW, Chang L, Strom JB, O'Brien C, Pomerantsev E, Yeh RW. Predicting the Presence of an Acute Coronary Lesion Among Patients Resuscitated From Cardiac Arrest. Circ Cardiovasc Interv. 2015 Oct; 8(10).
    View in: PubMed
    Score: 0.335
  31. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Response to Letter Regarding Article, "Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention". Circulation. 2015 Sep 22; 132(12):e156.
    View in: PubMed
    Score: 0.334
  32. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2014 Dec 23; 130(25):2295-301.
    View in: PubMed
    Score: 0.315
  33. Waldo SW, Armstrong EJ, Yeo KK, Patel M, Reeves R, Macgregor JS, Low RI, Mahmud E, Rogers JH, Shunk K. Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis. Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1048-53.
    View in: PubMed
    Score: 0.287
  34. Matheny ME, Carpenter-Song E, Ricket IM, Solomon RJ, Stabler ME, Davis SE, Zubkoff L, Westerman DM, Dorn C, Cox KC, Minter FF, Jneid H, Currier JW, Athar SA, Girotra S, Leung C, Helton TJ, Agarwal A, Vidovich MI, Plomondon ME, Waldo SW, Aschbrenner KA, McKay V, O'Malley AJ, Brown JR. Sustained Improvements After Intervention to Prevent Contrast-Associated Acute Kidney Injury: A Randomized Controlled Trial. J Am Heart Assoc. 2025 May 20; 14(10):e038920.
    View in: PubMed
    Score: 0.163
  35. Stein EJ, Mesenbring E, Smith T, Hebbe A, Salahuddin T, Waldo SW, Dyal MD, Doll JA. Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014528.
    View in: PubMed
    Score: 0.160
  36. Doll JA, Hebbe AL, Simons CE, Stein EJ, Eisenbarth S, Waldo SW, Rao SV, Au DH. Evaluation of Peer Review of Percutaneous Coronary Intervention Operator Performance. Circ Cardiovasc Qual Outcomes. 2025 Jan; 18(1):e011159.
    View in: PubMed
    Score: 0.159
  37. Kovach CP, Leonard J, Messenger JC, Waldo SW, Perman SM. Impact of Time to Initiation of Targeted Temperature Management Among Patients with Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention. Ther Hypothermia Temp Manag. 2025 Jun; 15(2):74-81.
    View in: PubMed
    Score: 0.156
  38. Gonzalez PE, Hebbe A, Hussain Y, Khera R, Banerjee S, Plomondon ME, Waldo SW, Pfau SE, Curtis JP, Shah SM. Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program. Am J Cardiol. 2024 07 01; 222:39-50.
    View in: PubMed
    Score: 0.152
  39. Parikh RV, Hebbe A, Bar?n AE, Grunwald GK, Plomondon ME, Gordin J, Yeh RW, Jneid H, Swaminathan RV, Waldo SW, Monto A, Secemsky E, Hsue PY. Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2023 02 21; 12(4):e028082.
    View in: PubMed
    Score: 0.140
  40. Swat SA, Hebbe A, Plomondon ME, Park KE, Bricker RS, Waldo SW, Valle JA. Contemporary Management Before Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2023 03; 16(3):e008949.
    View in: PubMed
    Score: 0.139
  41. Grines CL, Box LC, Mamas MA, Abbott JD, Blankenship JC, Carr JG, Curzen N, Kent WDT, Khatib Y, Matteau A, Rymer JA, Schreiber TL, Velagapudi P, Vidovich MI, Waldo SW, Seto AH. SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup. JACC Cardiovasc Interv. 2023 04 10; 16(7):847-860.
    View in: PubMed
    Score: 0.139
  42. Chambers JW, Martinsen BJ, Sturm RC, Mandair D, Valle JA, Waldo SW, Guzzetta F, Armstrong EJ. Orbital atherectomy of calcified coronary ostial lesions. Catheter Cardiovasc Interv. 2022 10; 100(4):553-559.
    View in: PubMed
    Score: 0.135
  43. Kini V, Parks M, Liu W, Waldo SW, Ho PM, Bradley SM, Hess PL. Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 06 01; 5(6):e2217704.
    View in: PubMed
    Score: 0.133
  44. Jovin IS, Warsavage TJ, Plomondon ME, Grunwald GK, Waldo SW, Rao SV, Brilakis ES, Azzalini L. Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program. Catheter Cardiovasc Interv. 2022 07; 100(1):85-93.
    View in: PubMed
    Score: 0.132
  45. Doll JA, Beaver K, Naranjo D, Waldo SW, Maynard C, Helfrich CD, Rao SV. Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011-2018. Circ Cardiovasc Qual Outcomes. 2022 05; 15(5):e008359.
    View in: PubMed
    Score: 0.131
  46. Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
    View in: PubMed
    Score: 0.131
  47. Doll JA, Nelson AJ, Kaltenbach LA, Wojdyla D, Waldo SW, Rao SV, Wang TY. Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality. Circ Cardiovasc Interv. 2022 01; 15(1):e010909.
    View in: PubMed
    Score: 0.128
  48. Nathan AS, Manandhar P, Wojdyla D, Nelson A, Fiorilli PN, Waldo S, Yeh RW, Rao SV, Fanaroff AC, Groeneveld PW, Wang TY, Giri J. Hospital-Level Percutaneous Coronary Intervention Performance With Simulated?Risk Avoidance. J Am Coll Cardiol. 2021 11 30; 78(22):2213-2217.
    View in: PubMed
    Score: 0.128
  49. Beaver K, Naranjo D, Doll J, Maynard C, Taylor L, Plomondon M, Waldo S, Helfrich CD, Rao SV. Design and baseline results of a coaching intervention for implementation of trans-radial access in percutaneous coronary intervention. Contemp Clin Trials. 2021 12; 111:106606.
    View in: PubMed
    Score: 0.128
  50. Brophy TJ, Warsavage TJ, Hebbe AL, Plomondon ME, Waldo SW, Rao SV, DeVore AD, Gutierrez JA, Swaminathan RV. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program. Am Heart J. 2021 05; 235:149-157.
    View in: PubMed
    Score: 0.121
  51. Prabhu KM, Don C, Sayre GG, Kearney KE, Hira RS, Waldo SW, Rao SV, Au DH, Doll JA. Interventional cardiologists' perceptions of percutaneous coronary intervention quality measurement and feedback. Am Heart J. 2021 05; 235:97-103.
    View in: PubMed
    Score: 0.121
  52. Sturm R, Armstrong EJ, Benhuri B, Okamoto N, Vengrenyuk Y, Shlofmitz E, Revtyak GE, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Aksut B, Bell S, Gardner R, Lee M, Zakir R, Shroff A, Don C, Shlofmitz R, Chambers JW, Kini A, Sharma S. Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter Analysis. Cardiovasc Revasc Med. 2021 05; 26:34-38.
    View in: PubMed
    Score: 0.119
  53. Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Bar?n AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
    View in: PubMed
    Score: 0.111
  54. Rymer JA, O'Donnell CI, Plomondon ME, Hess PL, Donahue M, Hebert PL, Shroff A, Swaminathan RV, Waldo SW, Seto AH, Helfrich CD, Rao SV. Same-day discharge among patients undergoing elective PCI: Insights from the VA CART Program. Am Heart J. 2019 12; 218:75-83.
    View in: PubMed
    Score: 0.110
  55. Sturm R, Martinsen BJ, Valle JA, Waldo SW, Behrens AN, Armstrong EJ. Orbital Atherectomy for Treatment of Complex Severely Calcified Coronary Artery Lesions: Insights from a Veterans Affairs Cohort. Cardiovasc Revasc Med. 2020 Mar; 21(3):330-333.
    View in: PubMed
    Score: 0.109
  56. Gutierrez JA, Bhatt DL, Banerjee S, Glorioso TJ, Josey KP, Swaminathan RV, Maddox TM, Armstrong EJ, Duvernoy C, Waldo SW, Rao SV. Risk of obstructive coronary artery disease and major adverse cardiac events in patients with noncoronary atherosclerosis: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) Program. Am Heart J. 2019 07; 213:47-56.
    View in: PubMed
    Score: 0.107
  57. Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, Kennedy KF, Masoudi FA, Yeh RW. Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative. JAMA Cardiol. 2019 02 01; 4(2):100-109.
    View in: PubMed
    Score: 0.106
  58. Hu PT, Jones WS, Glorioso TJ, Bar?n AE, Grunwald GK, Waldo SW, Maddox TM, Vidovich M, Banerjee S, Rao SV. Predictors and Outcomes of Staged?Versus One-Time Multivessel?Revascularization in Multivessel?Coronary?Artery Disease: Insights From the VA CART Program. JACC Cardiovasc Interv. 2018 11 26; 11(22):2265-2273.
    View in: PubMed
    Score: 0.104
  59. Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
    View in: PubMed
    Score: 0.103
  60. Yap J, Singh GD, Kim JS, Soni K, Chua K, Neo A, Koh CH, Armstrong EJ, Waldo SW, Shunk KA, Low RI, Hong MK, Jang Y, Yeo KK. Outcomes of primary percutaneous coronary intervention in acute myocardial infarction due to unprotected left main thrombosis: The Asia-Pacific Left Main ST-Elevation Registry (ASTER). J Interv Cardiol. 2018 Apr; 31(2):129-135.
    View in: PubMed
    Score: 0.097
  61. Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018 08 01; 92(2):285-299.
    View in: PubMed
    Score: 0.096
  62. Kobayashi T, Glorioso TJ, Armstrong EJ, Maddox TM, Plomondon ME, Grunwald GK, Bradley SM, Tsai TT, Waldo SW, Rao SV, Banerjee S, Nallamothu BK, Bhatt DL, Rene AG, Wilensky RL, Groeneveld PW, Giri J. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals. JAMA Cardiol. 2017 09 01; 2(9):967-975.
    View in: PubMed
    Score: 0.096
  63. Strom JB, McCabe JM, Waldo SW, Pinto DS, Kennedy KF, Feldman DN, Yeh RW. Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes. Circ Cardiovasc Interv. 2017 May; 10(5).
    View in: PubMed
    Score: 0.093
  64. Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT. Incomplete Revascularization Is Associated With an Increased Risk for?Major Adverse Cardiovascular Events?Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017 02 27; 10(4):329-338.
    View in: PubMed
    Score: 0.092
  65. McCabe JM, Waldo SW, Kennedy KF, Yeh RW. Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York. JAMA Cardiol. 2016 09 01; 1(6):648-54.
    View in: PubMed
    Score: 0.089
  66. Wiktor DM, Waldo SW, Armstrong EJ. Coronary Stent Failure: Fracture, Compression, Recoil, and Prolapse. Interv Cardiol Clin. 2016 07; 5(3):405-414.
    View in: PubMed
    Score: 0.088
  67. Armstrong EJ, Graham L, Waldo SW, Valle JA, Maddox TM, Hawn MT. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Catheter Cardiovasc Interv. 2017 Mar 01; 89(4):617-627.
    View in: PubMed
    Score: 0.088
  68. Yeo KK, Armstrong EJ, Soni K, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry. EuroIntervention. 2015 Jun; 11(2):188-95.
    View in: PubMed
    Score: 0.082
  69. Abtahian F, Waldo S, Jang IK. Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors. Catheter Cardiovasc Interv. 2015 Sep; 86(3):390-6.
    View in: PubMed
    Score: 0.081
  70. Armstrong EJ, Sab S, Singh GD, Lim W, Yeo KK, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. JACC Cardiovasc Interv. 2014 Oct; 7(10):1105-13.
    View in: PubMed
    Score: 0.078
  71. Wasfy JH, Strom JB, Waldo SW, O'Brien C, Wimmer NJ, Zai AH, Luttrell J, Spertus JA, Kennedy KF, Normand SL, Mauri L, Yeh RW. Clinical preventability of 30-day readmission after percutaneous coronary intervention. J Am Heart Assoc. 2014 Sep 26; 3(5):e001290.
    View in: PubMed
    Score: 0.078
  72. Reeves RR, Patel M, Armstrong EJ, Sab S, Waldo SW, Yeo KK, Shunk KA, Low RI, Rogers JH, Mahmud E. Angiographic characteristics of definite stent thrombosis: role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion. Catheter Cardiovasc Interv. 2015 Jan 01; 85(1):13-22.
    View in: PubMed
    Score: 0.076
  73. Keach JW, Stanislawski MA, Bar?n AE, Plomondon ME, Langner P, Amin A, Gilmartin HM, Waldo S, Maddox TM. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program. BMC Nephrol. 2020 04 28; 21(1):150.
    View in: PubMed
    Score: 0.029
  74. Parikh RV, Liu G, Plomondon ME, Sehested TSG, Hlatky MA, Waldo SW, Fearon WF. Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. 2020 02 04; 75(4):409-419.
    View in: PubMed
    Score: 0.028
  75. Nathan AS, Shah RM, Khatana SA, Dayoub E, Chatterjee P, Desai ND, Waldo SW, Yeh RW, Groeneveld PW, Giri J. Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest. Circ Cardiovasc Interv. 2019 04; 12(4):e007564.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)